Cannabis4 years ago
InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs, today revealed the...